Clinical validity and clinical utility of molecular-genetic laboratory testing

1. Brdička R, et al. Analytic Validation of Molecular Genetic Methods for Human Genom Analysis (Recommendation of SLG). Klin Biochem Metabol 2007; 1: 58–62.

2. Brdička R, et al. Clinical Validation of Genetic testing. Klin Biochem Metabol 2007; 1: 63.

3. Wang J, Shete S. A test for genetic association that incorporates information about deviation from Hardy-Weinberg proportions in cases. Am J Hum Genet 2008; 83: 53–63.

4. Harris H. Enzyme polymorphisms in man. Proc R Soc Lond B Biol Sci 1966; 164 (sv 995): 298–310.

5. Storgaard L, et al. Genetic and environmental correlates of semen quality a twin study Epidemiology 2006; 17: 674–681.

6. Distel MA, et al. Heritability of self-reported phobic fear. Broad-sense heritability estimates ranged from 36 to 51% and were similar for men and women. Behav Genet 2008; 38: 24–33.

7. Carbonaro F, et al. Heritability of intraocular pressure a classical twin study. Br J Ophthalmol 2008; 92: 1125–1128.

8. Willemsen G, et al. Heritability of self-reported asthma and allergy a study in adult. Dutch twins, siblings and parents. Twin Res Hum Genet 2008; 1: 132–142.

9. Sun J, et al. Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations. Prostate 2008; 68: 1257–1262.

10. Silventoinen K, et al. Heritability of body size and muscle strength in young adulthood a study of one million. Swedish men Genet Epidemiol 2008; 32: 341–349.

11. Marchini J, et al. The effects of human population structure on large genetic association studies. Nat Genet 2004; 36: 1129–1130.

12. Drake BF, et al. Racial differences in prostate cancer screening by family history. Ann Epidemiol 2008; 18: 579–583.

13. Cassidy-Bushrow AE, et al. Coronary artery calcification progression is heritable. Circulation 2007; 116: 25–31.

14. Hamdani N, et al. Heritability and candidate genes in tobacco use Encephale 2006; 32: 966–975.

15. Malkin I, et al. Heritability of a skeletal biomarker of biological aging. Biogerontology 2007; 8: 627–637.

16. Porteous D. Genetic causality in schizophrenia and bipolar disorder out with the old and in with the new. Curr Opin Genet Dev 2008; 18: 1–6.

17. Rybicki BA, Elston RC. The relationship between the sibling recurrence-risk ratio and genotype relative risk. Am J Hum Genet 2000; 66: 593–604.

18. Marchini J, et al. Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat Genet 2005; 37: 413–417.

19. Wray NR, et al. Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res 2007; 17: 1520–1528.

20. Offit K. Genomic profiles for disease risk. JAMA 2008; 299: 1353–1355.

21. Iles MM. What can genome-wide association studies tell us about the genetics of common disease. PLoS Genet 2008; e33.

22. Tan Q, et al. Retrospective analysis of main and interaction effects in genetic association studies of human complex traits. BMC Genet 2007; 870.

23. Chung Y, et al. Odds ratio based multifactor-dimensionality reduction method for detecting gene-gene interactions Bioinformatics 2007; 23: 71–76.

24. Chen SH, et al. A support vector machine approach for detecting gene-gene interaction Genet Epidemiol 2008; 32: 152–167.

25. Ambrosini GL, et al. Dietary patterns identified using factor analysis and prostate cancer risk a case control study in Western Australia. Ann Epidemiol 2008; 18: 364–370.

26. Mink PJ, et al. Pesticides and prostate cancer a review of epidemiologic studies with specific agricultural exposure information. Eur J Cancer Prev 2008; 17: 97–110.

27. Chávez A, MuĖoz de Chávez M. Nutrigenomics in public health nutrition short-term perspectives. Eur J Clin Nutr 2003; 57 (Suppl 1): S97–S100.

28. Ullah MF, Khan MW. Food as medicine potential therapeutic tendencies of plant derived polyphenolic compounds. Asian Pac J Cancer Prev 2008; 9: 187–196.

29. Įrstavik RE, et al. Genetic and environmental contributions to depressive personality disorder in a population-based sample of Norwegian twins. J Affect Disord 2007; 99: 181–189.

30. Waters M, Jackson M. Databases applicable to quantitative hazard/risk assessment-Towards a predictive systems toxicology. Toxicol Appl Pharmacol 2008; 233: 34–44.

31. Rigby AS, et al. HLA haplotype sharing in rheumatoid arthritis sibships risk estimates subdivided by proband genotype. Genet Epidemiol 1998; 15: 403–418.

32. Chakraborty R. Statistical Basis of Risk Calculationsin Handbook od Statistical Genetics. Balding DJ, Bishop M, Cannings C. (eds). New York: John Wiley & Sons Ltd 2001.

33. Beuten J, et al. CYP1B1 variants are associated with Prostate Cancer in non-Hispanic and Hispanic Caucasians Carcinogenesis 2008; 29: 1751–1757.

34. Holt SK, et al. Association of megalin genetic polymorphisms with prostate cancer risk and prognosis. Clin Cancer Res 2008; 14: 3823–3831.

35. Huse K, et al. Genetic variants of the copy number polymorphic beta-defensin locus are associated with sporadic prostate cancer. Tumour Biol 2008; 29: 83–92.

36. Narod SA, et al. Rapid progression of prostate cancer in men with a BRCA2 mutation. Br J Cancer 2008; 99: 371–374.

37. Ostrander EA, Johannesson B. Prostate cancer susceptibility loci finding the genes. Adv Exp Med Biol 2008; 617: 179–190.

38. Wakefield CE, et al. Issues faced by unaffected men with a family history of prostate cancer a multidisciplinary overview J Urol 2008; 180: 38–46.

39. Hemminki K, et al. New cancer susceptibility loci: Population and familial risks. Int J Cancer 2008; 123: 1726–1729.

40. Arsova-Sarafinovska Z, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer. Cell Biochem Funct 2008 26: 771–777.

41. Mechanic, LE. Polymorphism Interaction Analysis (PIA) a method for investigating complex gene-gene interactions. BMC Bioinformatics 2008; 9: 146.

42. Clarke J, West, M. Bayesian Weibull tree models for survival analysis of clinico-genomic data. Stat Methodol 2008; 5: 238–246.

43. Schliekelman P, Slatkin M. Multiplex relative risk and estimation of the number of loci underlying an inherited disease. Am J Hum Genet 2002; 71: 1369–1385.

44. Schliekelman P. Statistical power of expression quantitative trait loci for mapping of complex trait loci in natural populations. Genetics 2008; 178: 2201–2216.

45. Lasky-Su J, et al. On the replication of genetic associations timing can be everything! Am J Hum Genet 2008; 82: 849–858.

46. Slatkin M. Genotype-specific recurrence risks as indicators of the genetic architecture of complex diseases. Am J Hum Genet 2008; 83: 120–126.

47. Li J. A novel strategy for detecting multiple loci in Genome-Wide Association Studies of complex diseases. Int J Bioinform Res Appl 2008; 4: 150–163.

48. Dodsworth S. SNP genotyping aids diagnostic development. GEN 2008; 28: 50–52.

49. Herceg Z. Epigenetics and cancer towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 2007; 22: 91–103.

50. Olden K, White SL. Health-related disparities influence of environmental factors. Med Clin North Am 2005; 89: 721–738.

51. Olden K. Toxicogenomics – a new systems toxicology approach to understanding of gene-environment interactions. Ann NY Acad Sci 2006; 107: 6703–6706.

52. Ishikawa H, et al. A polymorphism of the methionine synthase reductase gene increases chromosomal damage in peripheral lymphocytes in smokers. Mutat Res 2006; sv 599: 135–143.

53. Ishikawa H, et al. Genotoxic effects of alcohol in human peripheral lymphocytes modulated by ADH1B and ALDH2 gene polymorphisms. Mutat Res 2007; sv 615: 134–142.

54. Fontaine-Bisson B, et al. Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A–I concentrations. Am J Clin Nutr 2007; 86: 768–774.

Přívažek:

adresy programů genetického vyhodnocování:

http://linkage.rockefeller.edu/soft/list.html